Big Gain For Renovaro Biosciences Inc.
Wed, Feb 26, 2025 at 07:38 PM
Renovaro Biosciences Inc. (RENB:NASDAQ) rocketted at $1.19, a gain of 53.9%. On Wed, Feb 26, 2025, RENB:NASDAQ touched a New 2-Week High of $1.19. The stock appeared on our News Catalysts scanner on Wed, Feb 26, 2025 at 04:26 PM in the 'AGREEMENT' category. From Thu, Feb 13, 2025, the stock recorded 62.50% Up Days and 33.33% Green Days
The stock spiked on Mon, Dec 09, 2024 at $2.1 with a volume of 1M+.
About Renovaro Biosciences Inc. (RENB:NASDAQ)
Enochian BioSciences Inc is a biopharmaceutical company. It is engaged in identifying, developing, manufacturing, and commercializing gene therapies.
Top 10 Gainers:
- Enveric Biosciences Inc. (ENVB:NASDAQ), 94.92%
- Heramba Electric plc (PITA:NASDAQ), 86.59%
- Porch Group Inc. (PRCH:NASDAQ), 74.14%
- Mullen Automotive Inc. (MULN:NASDAQ), 71.19%
- Renovaro Biosciences Inc. (RENB:NASDAQ), 53.95%
- PicoCELA Inc. (PCLA:NASDAQ), 35.6%
- B. Riley Financial, Inc. (RILY:NASDAQ), 35.58%
- Moolec Science SA (MLEC:NASDAQ), 34.49%
- Aureus Greenway Holdings Inc. (AGH:NASDAQ), 34.15%
- Interactive Strength Inc. (TRNR:NASDAQ), 31.62%